The field tells cells where to act. The bioregulator tells cells what to make. Together they form the next axis of regenerative medicine — built on five decades of peer-reviewed work and organized here as a single coherent reference.
The signaling pathway is fully characterized in peer-reviewed literature. The field arrives. The membrane transduces through adenosine A2A and A3 receptors. The mitochondria respond with hormetic ATP and ROS. The nucleus activates the canonical Wnt/β-catenin–Runx2–BMP2 program — the same gates the bioregulators of endogenic pharmacology have always targeted.
Structured pulsed electromagnetic fields prime cellular machinery — opening ion channels, modulating mitochondria, restoring bioelectric pattern, and conditioning the structured-water substrate that surrounds every regenerating cell. Built on the Becker–Levin lineage at SUNY Upstate and Tufts.
The four-layer modelShort peptide bioregulators of two to seven amino acids arrive in primed cells and modulate gene expression from within the body's own regulatory architecture. The Khavinson lineage, extended through proprietary acetylated and amidated analogs designed for non-injectable delivery.
The bioregulator classRobert Becker's regeneration current at SUNY Upstate. Vladimir Khavinson's peptide bioregulator literature at the Saint Petersburg Institute. The FDA's 1979 approval of pulsed electromagnetic field stimulation for non-union bone. Gerald Pollack's exclusion-zone water at the University of Washington. Michael Levin's morphogenetic code at Tufts. Organized here as one platform.
Bioregulators alone are pure chemistry — they bind, activate, and diffuse, with no spatial control. Pulsed electromagnetic fields alone are pure context — they prime, gate, and pattern, with no cargo. Bioelectric regeneration completes endogenic pharmacology. Endogenic pharmacology completes bioelectric regeneration.
The science. Studies how structured pulsed electromagnetic fields prime cellular machinery — opening ion channels, modulating mitochondria, restoring bioelectric pattern, and conditioning the structured-water substrate. Built on the Becker–Levin lineage at SUNY Upstate and Tufts.
Learn more →The cargo. Short peptide bioregulators of two to seven amino acids that arrive in primed cells and modulate gene expression from within the body's own regulatory architecture. Khavinson lineage, extended through the proprietary trade-named portfolio — Telogenix™, Thymogenix™, Vasogenix™, Dermogenix™, Cortigenix™, Lymphogenix™, and Gonadogenix™ — terminus modified analogs.
Learn more →A tri-axis Helmholtz coil array with embedded near-infrared emitters and integrated bioregulator-delivery synchronization — runs the four-layer field protocol and the paired peptide cargo in a single calibrated session.
Learn more →“Bioelectric regeneration and endogenic pharmacology are halves of one platform. The field opens what the bioregulator was always meant to enter — a primed cell, ready to act on the instructions that short peptides carry. We are honored to organize the integrated discipline and to provide its canonical reference.”